Vanguard Fiduciary Trust
CNTB

Vanguard Fiduciary Trust’s Connect Biopharma Holdings CNTB Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9K Buy
+11,314
New +$27.4K ﹤0.01% 3959

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Vanguard Fiduciary Trust's CNTB Position: Q2 2026 in Review

Vanguard Fiduciary Trust opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 11,314 shares worth $26.9K. The stake represents ﹤0.01% of the portfolio and ranks #3959 among its holdings.

56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Vanguard Fiduciary Trust held 11,314 shares of Connect Biopharma Holdings worth $26.9K as of Q2 2026.
  • Connect Biopharma Holdings was a new Vanguard Fiduciary Trust position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3959 holding.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.